Article Versions Notes

Wong G, Wang K, Pasetka M, Zhang L, Lou J, Majeed H, Flores J, Lam E, DeAngelis C. The Real-World Experience of the Biosimilar (Grastofil^®) to the Reference Biologic (Neupogen^®) in Breast Cancer and Lymphoma: A Canadian Single-Centre Retrospective Study. Current Oncology. 2022; 29(3):1349-1369. https://doi.org/10.3390/curroncol29030115

Wong, Gina, Katie Wang, Mark Pasetka, Liying Zhang, Julia Lou, Habeeb Majeed, Jerome Flores, Emily Lam, and Carlo DeAngelis. 2022. "The Real-World Experience of the Biosimilar (Grastofil^®) to the Reference Biologic (Neupogen^®) in Breast Cancer and Lymphoma: A Canadian Single-Centre Retrospective Study" Current Oncology 29, no. 3: 1349-1369. https://doi.org/10.3390/curroncol29030115

Wong, G., Wang, K., Pasetka, M., Zhang, L., Lou, J., Majeed, H., Flores, J., Lam, E., & DeAngelis, C. (2022). The Real-World Experience of the Biosimilar (Grastofil^®) to the Reference Biologic (Neupogen^®) in Breast Cancer and Lymphoma: A Canadian Single-Centre Retrospective Study. Current Oncology, 29(3), 1349-1369. https://doi.org/10.3390/curroncol29030115